The University of Tennessee College of Medicine, Chattanooga, USA.
The University of Tennessee Health Science Center, Memphis, USA.
Hand (N Y). 2021 Jan;16(1):18-24. doi: 10.1177/1558944719840735. Epub 2019 Apr 2.
The etiology of recurrent carpal tunnel syndrome (CTS) is unclear, and outcomes following secondary surgery in this demographic have been poorer than primary surgery. Fibrosis and hypertrophy have been identified in the flexor tenosynovium in these patients. The authors use flexor tenosynovectomy (FTS) for recurrent CTS after primary carpal tunnel release and present a review of these patients. A retrospective chart review was performed of 108 cases of FTS for recurrent CTS from 1995 to 2015 by 4 attending surgeons at one institution. Demographic information, symptoms, and outcomes were among the data recorded. A phone survey was conducted on available patients where the shortened version of the Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH) and satisfaction were assessed. Average office follow-up was 12 months. Average age was 57.5 years. A total of 104 (96%) reported symptom improvement and 48 (44%) reported complete symptom resolution. Forty patients were available for long-term follow-up at an average 6.75 years postoperatively via phone interview. Average QuickDASH score was 31.2 in these patients. Thirty-six (90%) of 40 patients were initially satisfied at last office visit, and 31 (78%) of 40 were satisfied at average 6.9 years, a maintenance of satisfaction of 86%. Satisfied patients were older (58 years) than unsatisfied patients (51 years). Both long-term satisfaction and QuickDASH scores in our cohort are consistent with or better than published results from nerve-shielding procedures. The authors believe a decrease in both carpal tunnel volume and potential adhesions of fibrotic or inflammatory synovium contributes to the benefits of this procedure. This remains our procedure of choice for recurrent CTS.
复发性腕管综合征(CTS)的病因尚不清楚,且此类患者接受二次手术后的效果不如初次手术。在这些患者中,屈肌肌腱滑膜出现纤维化和肥大。作者对初次腕管松解术后复发性 CTS 患者采用屈肌肌腱滑膜切除术(FTS),并对这些患者进行了回顾性研究。对 1995 年至 2015 年间由 4 位主治医生在一家机构进行的 108 例 FTS 治疗复发性 CTS 的病例进行了回顾性图表分析。记录了人口统计学信息、症状和结果等数据。对可获得的患者进行了电话调查,评估了简化版的上肢残疾问卷(QuickDASH)和满意度。平均随访时间为 12 个月。平均年龄为 57.5 岁。共有 104 例(96%)报告症状改善,48 例(44%)报告完全症状缓解。通过电话访谈,40 例患者在平均 6.75 年的术后随访中获得了长期随访。这些患者的平均 QuickDASH 评分为 31.2。36 例(90%)患者在最后一次就诊时最初表示满意,40 例中有 31 例(78%)在平均 6.9 年时表示满意,满意度维持在 86%。满意的患者比不满意的患者年龄大(58 岁比 51 岁)。在我们的队列中,长期满意度和 QuickDASH 评分均与神经保护手术的结果一致或更好。作者认为,腕管容积的减少以及纤维化或炎症性滑膜的潜在粘连有助于该手术的效果。这仍然是我们治疗复发性 CTS 的首选方法。